Explore
Validate
Learn
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN111970 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Protein P53 (TP53) (AA 16-25) antibody (FITC)
- Antibody type
- Monoclonal
- Reactivity
- Human, Simian
- Host
- Mouse
- Conjugate
- Green dye
- Epitope
- AA 16-25
- Isotype
- IgG
- Antibody clone number
- BP53-12
- Vial size
- 0.1 mg
- Storage
- Store the antibody prior to reconstitution at -20°C. Following reconstitution the antibody can be stored at 2-8°C for one month or at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells.
Mechanisms of G2 arrest in response to overexpression of p53.
p53 inhibits entry into mitosis when DNA synthesis is blocked.
A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides.
Epitope analysis of the human p53 tumour suppressor protein.
p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.
Tanigawa S, Fujii M, Hou DX
Bioscience, biotechnology, and biochemistry 2008 Mar;72(3):797-804
Bioscience, biotechnology, and biochemistry 2008 Mar;72(3):797-804
Mechanisms of G2 arrest in response to overexpression of p53.
Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schönthal AH, Katula KS, Stark GR
Molecular biology of the cell 1999 Nov;10(11):3607-22
Molecular biology of the cell 1999 Nov;10(11):3607-22
p53 inhibits entry into mitosis when DNA synthesis is blocked.
Taylor WR, Agarwal ML, Agarwal A, Stacey DW, Stark GR
Oncogene 1999 Jan 14;18(2):283-95
Oncogene 1999 Jan 14;18(2):283-95
A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides.
Agarwal ML, Agarwal A, Taylor WR, Chernova O, Sharma Y, Stark GR
Proceedings of the National Academy of Sciences of the United States of America 1998 Dec 8;95(25):14775-80
Proceedings of the National Academy of Sciences of the United States of America 1998 Dec 8;95(25):14775-80
Epitope analysis of the human p53 tumour suppressor protein.
Dolezalová H, Vojtĕsek B, Kovarík J
Folia biologica 1997;43(1):49-51
Folia biologica 1997;43(1):49-51
p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.
Agarwal ML, Agarwal A, Taylor WR, Stark GR
Proceedings of the National Academy of Sciences of the United States of America 1995 Aug 29;92(18):8493-7
Proceedings of the National Academy of Sciences of the United States of America 1995 Aug 29;92(18):8493-7
Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Lukás J, Rejthar A, Kovarík J, Midgley CA, Gannon JV, Lane DP
Oncogene 1991 Sep;6(9):1699-703
Oncogene 1991 Sep;6(9):1699-703
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.
Bártková J, Bártek J, Lukás J, Vojtĕsek B, Stasková Z, Rejthar A, Kovarík J, Midgley CA, Lane DP
International journal of cancer 1991 Sep 9;49(2):196-202
International journal of cancer 1991 Sep 9;49(2):196-202
No comments: Submit comment
No validations: Submit validation data